Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: A phase Ib dose-finding study

S. De Vos, L. J. Swinnen, D. Wang, E. Reid, N. Fowler, J. Cordero, M. Dunbar, S. H. Enschede, C. Nolan, A. M. Petrich, J. A. Ross, A. H. Salem, M. Verdugo, S. Agarwal, L. Zhou, M. Kozloff, L. J. Nastoupil, C. R. Flowers

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: A phase Ib dose-finding study'. Together they form a unique fingerprint.

Medicine & Life Sciences